{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T20:39:06Z","timestamp":1764794346551,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":35,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071631744"},{"type":"electronic","value":"9781071631751"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3175-1_16","type":"book-chapter","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:02:13Z","timestamp":1684479733000},"page":"263-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lupus Anticoagulant Testing: Taipan Snake Venom Time with Ecarin Time as Confirmatory Test"],"prefix":"10.1007","author":[{"given":"Gary W.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/jth.13976","volume":"16","author":"KMJ Devreese","year":"2018","unstructured":"Devreese KMJ, Ortel TL, Pengo V, de Laat B (2018) Subcommittee on lupus anticoagulant\/antiphospholipid antibodies. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. J Thromb Haemost 16:809\u2013813","journal-title":"J Thromb Haemost"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","volume":"157","author":"D Keeling","year":"2012","unstructured":"Keeling D, Mackie I, Moore GW, Greer IA, Greaves M (2012) British Committee for Standards in haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 157:47\u201358","journal-title":"Br J Haematol"},{"key":"16_CR3","volume-title":"Laboratory testing for the lupus anticoagulant; approved guideline. CLSI document H60-A","author":"CLSI","year":"2014","unstructured":"CLSI (2014) Laboratory testing for the lupus anticoagulant; approved guideline. CLSI document H60-A. Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1111\/jth.15047","volume":"18","author":"KMJ Devreese","year":"2020","unstructured":"Devreese KMJ, de Groot PG, de Laat B, Erkan D, Favaloro EJ, Mackie I, Martinuzzo M, Ortel TL, Pengo V, Rand JH, Tripodi A, Wahl D, Cohen H (2020) Guidance from the Scientific and Standardisation Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 18:2828\u20132839","journal-title":"J Thromb Haemost"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/jth.14846","volume":"18","author":"A Tripodi","year":"2020","unstructured":"Tripodi A, Cohen H, Devreese KMJ (2020) Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 18:1569\u20131575","journal-title":"J Thromb Haemost"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1515\/cclm-2019-1248","volume":"58","author":"GW Moore","year":"2019","unstructured":"Moore GW (2019) Mixing studies for lupus anticoagulant: mostly no, sometimes yes. Clin Chem Lab Med 58:492\u2013495","journal-title":"Clin Chem Lab Med"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/jth.13020","volume":"13","author":"KM Devreese","year":"2015","unstructured":"Devreese KM, de Laat B (2015) Mixing studies in lupus anticoagulant testing are required at least in some type of samples. J Thromb Haemost 13:1475\u20131478","journal-title":"J Thromb Haemost"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.thromres.2005.09.010","volume":"118","author":"GW Moore","year":"2006","unstructured":"Moore GW, Savidge GF (2006) The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thromb Res 118:523\u2013528","journal-title":"Thromb Res"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/rth2.12264","volume":"4","author":"PMM De Kesel","year":"2019","unstructured":"De Kesel PMM, Devreese KMJ (2019) The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: can activated carbon eliminate false-positive results? Res Pract Thromb Haemost 4:161\u2013168","journal-title":"Res Pract Thromb Haemost"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ajh.25836","volume":"95","author":"GW Moore","year":"2020","unstructured":"Moore GW (2020) Alternative assays to dRVVT and aPTT for lupus anticoagulant detection. Am J Hematol 95:992\u2013998","journal-title":"Am J Hematol"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1111\/jth.15438","volume":"19","author":"GW Moore","year":"2021","unstructured":"Moore GW, Jones PO, Platton S, Hussain N, White D, Thomas W, Rigano J, Pouplard C, Gray E, Devreese KMJ (2021) International multicenter, multiplatform study to validate Taipan snake venom time as a lupus anticoagulant screening test with ecarin time as the confirmatory test: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies. J Thromb Haemost 19:3177\u20133192","journal-title":"J Thromb Haemost"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1055\/s-0041-1732465","volume":"48","author":"GW Moore","year":"2022","unstructured":"Moore GW (2022) Snake venoms in diagnostic hemostasis and thrombosis. Semin Thromb Hemost 48:145\u2013160","journal-title":"Semin Thromb Hemost"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/jcp.47.6.497","volume":"47","author":"AM Rooney","year":"1994","unstructured":"Rooney AM, McNally T, Mackie IJ, Machin SJ (1994) The Taipan snake venom time: a new test for lupus anticoagulant. J Clin Pathol 47:497\u2013501","journal-title":"J Clin Pathol"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/01.mbc.0000061283.28953.39","volume":"14","author":"GW Moore","year":"2003","unstructured":"Moore GW, Smith MP, Savidge GF (2003) The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants. Blood Coagul Fibrinolysis 14:307\u2013312","journal-title":"Blood Coagul Fibrinolysis"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1055\/s-0038-1649701","volume":"70","author":"DA Triplett","year":"1993","unstructured":"Triplett DA, Stocker KF, Unger GA, Barna LK (1993) The Textarin\/Ecarin ratio: a confirmatory test for lupus anticoagulants. Thromb Haemost 70:925\u2013931","journal-title":"Thromb Haemost"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0049-3848(99)00096-1","volume":"96","author":"R Luddington","year":"1999","unstructured":"Luddington R, Scales C, Baglin T (1999) Lupus anticoagulant testing with optical end point automation. Thromb Res 96:197\u2013203","journal-title":"Thromb Res"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-9560-5-12","volume":"5","author":"GW Moore","year":"2007","unstructured":"Moore GW (2007) Combining Taipan snake venom time\/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients. Thromb J 5:12","journal-title":"Thromb J"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MBC.0b013e3283256037","volume":"20","author":"K Parmar","year":"2009","unstructured":"Parmar K, Lefkou E, Doughty H, Connor P, Hunt BJ (2009) The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist. Blood Coagul Fibrinolysis 20:271\u2013275","journal-title":"Blood Coagul Fibrinolysis"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/jth.12917","volume":"13","author":"DR Arachchillage","year":"2015","unstructured":"Arachchillage DR, Mackie IJ, Efthymiou M, Isenberg DA, Machin SJ, Cohen H (2015) Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. J Thromb Haemost 13:1264\u20131273","journal-title":"J Thromb Haemost"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/j.1538-7836.2011.04395.x","volume":"9","author":"GM van Os","year":"2011","unstructured":"van Os GM, de Laat B, Kamphuisen PW, Meijers JC, de Groot PG (2011) Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time. J Thromb Haemost 9:1657\u20131659","journal-title":"J Thromb Haemost"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/MBC.0000000000000486","volume":"27","author":"GW Moore","year":"2016","unstructured":"Moore GW, Culhane AP, Maloney JC, Archer RA, Breen KA, Hunt BJ (2016) Taipan snake venom time coupled with ecarin time testing enhances lupus anticoagulant detection in non-anticoagulated patients. Blood Coagul Fibrinolysis 27:477\u2013480","journal-title":"Blood Coagul Fibrinolysis"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1111\/ijlh.12611","volume":"39","author":"C Pouplard","year":"2017","unstructured":"Pouplard C, Vayne C, Berthomet C, Guery EA, Delahousse B, Gruel Y (2017) The Taipan snake venom time can be used to detect lupus anticoagulant in patients treated by rivaroxaban. Int J Lab Hematol 39:e60\u2013e63","journal-title":"Int J Lab Hematol"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/ced.14229","volume":"45","author":"A Cunliffe","year":"2020","unstructured":"Cunliffe A, Dobson J, Swallow G, Ravenscroft J, Tang TS (2020) Taipan snake venom time for antiphospholipid syndrome solves a 20-year diagnostic challenge. Clin Exp Dermatol 45:805\u2013808","journal-title":"Clin Exp Dermatol"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/ijlh.12006","volume":"35","author":"GW Moore","year":"2013","unstructured":"Moore GW, Brown KL, Bromidge ES, Drew AJ, Ledford-Kraemer MR (2013) Lupus anticoagulant detection: out of control? Int J Lab Hematol 35:128\u2013136","journal-title":"Int J Lab Hematol"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1182\/asheducation-2014.1.321","volume":"1","author":"SA Krilis","year":"2014","unstructured":"Krilis SA, Giannakopoulos B (2014) Laboratory methods to detect antiphospholipid antibodies. Hematology Am Soc Hematol Educ Program 1:321\u2013328","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.11613\/BM.2016.034","volume":"26","author":"F Habibzadeh","year":"2016","unstructured":"Habibzadeh F, Habibzadeh P, Yadollahie M (2016) On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Med (Zagreb) 26:297\u2013307","journal-title":"Biochem Med (Zagreb)"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/jth.14560","volume":"17","author":"H Cohen","year":"2019","unstructured":"Cohen H, Mackie IJ, Devreese KMJ (2019) International Society for Thrombosis and Haemostasis Scientific and Standardization Committee for Lupus Anticoagulant\/Antiphospholipid Antibodies. Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey. J Thromb Haemost 17:1715\u20131732","journal-title":"J Thromb Haemost"},{"key":"16_CR28","series-title":"CLSI document C28-A3","volume-title":"Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline","author":"CLSI","year":"2008","unstructured":"CLSI (2008) Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline, CLSI document C28-A3, 3rd edn. Clinical and Laboratory Standards Institute, Wayne, PA","edition":"3"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/00001721-200012000-00011","volume":"11","author":"GW Moore","year":"2000","unstructured":"Moore GW, Savidge GF, Smith MP (2000) Improved detection of lupus anticoagulants by the dilute Russell\u2019s Viper venom time. Blood Coagul Fibrinolysis 11:767\u2013774","journal-title":"Blood Coagul Fibrinolysis"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1111\/j.1538-7836.2010.04090.x","volume":"8","author":"EJ Favaloro","year":"2010","unstructured":"Favaloro EJ, Bonar R, Zebeljan D, Kershaw G, Marsden K (2010) Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost 8:2828\u20132831","journal-title":"J Thromb Haemost"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2257.2004.00644.x","volume":"26","author":"GW Moore","year":"2004","unstructured":"Moore GW, Kamat AV, Gurney DA, O\u2019Connor O, Rangarajan S, Carr R, Savidge GF (2004) Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin\u2019s lymphoma. Clin Lab Haematol 26:429\u2013434","journal-title":"Clin Lab Haematol"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/rth2.12006","volume":"1","author":"GW Moore","year":"2017","unstructured":"Moore GW, Maloney JC, de Jager N, Dunsmore CL, Gorman DK, Polgrean RF, Bertolaccini ML (2017) Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples. Res Pract Thromb Haemost 1:62\u201368","journal-title":"Res Pract Thromb Haemost"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1515\/cclm-2019-1240","volume":"58","author":"E Favaloro","year":"2020","unstructured":"Favaloro E (2020) Mixing studies for lupus anticoagulant: mostly yes, sometimes no. Clin Chem Lab Med 58:487\u2013491","journal-title":"Clin Chem Lab Med"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1160\/TH12-11-0850","volume":"110","author":"V Chantarangkul","year":"2013","unstructured":"Chantarangkul V, Biguzzi E, Asti D, Palmucci C, Tripodi A (2013) Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant. Thromb Haemost 110:46\u201352","journal-title":"Thromb Haemost"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/ajcp\/aqz151","volume":"153","author":"CH Murphy","year":"2020","unstructured":"Murphy CH, Jin J, Zehnder JL (2020) Antiphospholipid antibodies in patients with lupus anticoagulant prozone effect. Am J Clin Pathol 153:229\u2013234","journal-title":"Am J Clin Pathol"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3175-1_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:05:38Z","timestamp":1684479938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3175-1_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071631744","9781071631751"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"20 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}